Evidence map›Paper›PMID 41518550›Full record

ArticleMikrochimica acta2026

Oxidase activity-enhanced manganese (III) oxide nanozyme grown in dendritic mesoporous silica nanoparticles for sensitive lateral flow immunoassay of C-reactive protein.

Jiaqi Fang, Fang Gao, Ye Zhang, Yining Yao, Shaonian Ye, Chao Liu, Chengzhong Yu

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiaqi FangSchool of Chemistry and Molecular Engineering,, East China Normal University, Shanghai, PR, 200241, China.
Fang GaoInstitute of Energy Materials Science, University of Shanghai for Science and Technology, Shanghai, PR, 200093, China. fgao@usst.edu.cn.ORCID 0000-0002-5224-3843
Ye ZhangSchool of Chemistry and Molecular Engineering,, East China Normal University, Shanghai, PR, 200241, China.
Yining YaoAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland Brisbane, Queensland, 4072, Australia.
Shaonian YeInstitute of Energy Materials Science, University of Shanghai for Science and Technology, Shanghai, PR, 200093, China.
Chao LiuSchool of Chemistry and Molecular Engineering,, East China Normal University, Shanghai, PR, 200241, China. cliu@chem.ecnu.edu.cn.ORCID 0000-0003-0316-4994
Chengzhong YuSchool of Chemistry and Molecular Engineering,, East China Normal University, Shanghai, PR, 200241, China. c.yu@uq.edu.au.ORCID 0000-0003-3707-0785

Funding

National Natural Science Foundation of China 21905092National Natural Science Foundation of China 22475072Natural Science Foundation of Shanghai Municipality 25ZR1402379
6 · The paper itself

Abstract

The development of cost-effective nanozymes with signal amplification function to overcome the limited sensitivity of lateral flow immunoassays (LFIAs) is of great significance. Here, we introduce the first Mn

Indexed as

C-Reactive ProteinManganese CompoundsNanoparticlesOxidesOxidoreductasesSilicon DioxideCatalysisColorimetryHumansImmunoassayLimit of DetectionPorosityC-Reactive ProteinManganese Compoundsmanganese oxideOxidesOxidoreductasesSilicon DioxideColorimetric LFIA platformC-reactive proteinLateral flow immunoassayManganese oxideMesoporous silica nanoparticleOxidase-like nanozyme

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.